Lataa...
Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid‐range, and reduced left ventricular ejection fraction
AIMS: Patients with concomitant atrial fibrillation (AF) and reduced left ventricular ejection fraction (LVEF) have poor prognosis. Outcomes of novel oral anticoagulant (NOAC) in elderly AF patients with normal, mid‐range, and reduced LVEF were investigated. METHODS AND RESULTS: Data were retrieved...
Tallennettuna:
| Julkaisussa: | ESC Heart Fail |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7524083/ https://ncbi.nlm.nih.gov/pubmed/32677373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12890 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|